
Spherix Global Insights
@spherixinsights
Spherix Global Insights is a leading provider of market research, business intelligence and advisory services to the global life sciences industry.
ID: 4025773487
http://www.spherixglobalinsights.com/ 23-10-2015 17:47:03
875 Tweet
326 Takipçi
817 Takip Edilen

Today, Akebia Therapeutics received a response from the FDA's Office of New Drugs denying their appeal but offering guidance for resubmitting the new drug application for vadadustat, intended for the treatment of anemia in dialysis-dependent patients with chronic kidney disease.
